Among whole spectrum of somatic mutations in multiple generations of mouse MLL/AF9-AML transplantation from eight different strains, we extracted candidate driver mutations according to two criteria; (1) mutations recurrently identified in the multiple independent strains or (2) mutations reported in human hematological neoplasms. This evidence concerns the gene KMT2A and hematopoietic and lymphoid system neoplasm.